ArticlePerspectives in clinical research
Artificial intelligence in managing clinical trial design and conduct: Man and machine still on the learning curve?
Article in Perspectives in clinical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- From API to Action: A Multi-Model Comparison of OpenAI, Anthropic, Google, and Meta LLMs for Clinical Trial Data Extraction.Bioengineering (Basel, Switzerland) · 2026Article
- AI in Clinical Trials and Drug Development: Challenges and Potential Advancements.Current drug discovery technologies · 2025Review
- A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1.Journal of clinical medicine · 2023Article
- Large Language Models for Healthcare Data Augmentation: An Example on Patient-Trial Matching.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2023Article
- Artificial Intelligence for Predicting and Diagnosing Complications of Diabetes.Journal of diabetes science and technology · 2023Article
- The role of artificial intelligence in hastening time to recruitment in clinical trials.BJR open · 2023Review
- How can artificial intelligence optimize value-based contracting?Journal of pharmaceutical policy and practice · 2022Article
- Article
- Scaling up artificial intelligence to curb infectious diseases in Africa.Frontiers in digital health · 2022Article
- Artificial intelligence in pharmacovigilance - Opportunities and challenges.Perspectives in clinical researchReview
- Exploring the bioethical implications of using artificial intelligence in writing research proposals.Perspectives in clinical researchReview
- Applied intelligence in clinical drug development: Potential benefits and emerging concerns.Perspectives in clinical researchReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.